Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05323123 · ClinicalTrials.gov registry record · NA
Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT05323123 is a NA study that has completed, run by Columbia University. The registered enrollment target is 120 participants.
The verdict
NCT05323123, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
To stem increasing rates of HIV among gay and bisexual men in Central-Eastern Europe, the feasibility, acceptability, and early efficacy of a culturally adapted evidence-based program to introduce pre-exposure prophylaxis (PrEP) into Romania's healthcare practice will be established. PrEP Romania, a hybrid in-person + mHealth PrEP uptake and adherence program, aims to empower gay and bisexual men and their healthcare system to adopt PrEP and support adherence. Findings can inform evidence-based PrEP rollout in other Central-Eastern European countries with similar levels of unpreparedness for biomedical prevention.
Interventions
- BEHAVIORAL PrEP Education
- BEHAVIORAL SPARK
- BEHAVIORAL HealthMpowerment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05323123
The ClinicalTrials.gov registry entry for NCT05323123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PrEP Education is the first listed.
NCT05323123 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05323123 about?
NCT05323123 is a clinical study titled "Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries". To stem increasing rates of HIV among gay and bisexual men in Central-Eastern Europe, the feasibility, acceptability, and early efficacy of a culturally adapted evidence-based program to introduce pre-exposure prophylaxis (PrEP) into Romania's healthcare practice will be established. PrEP Romania, a...
What is the current status of trial NCT05323123?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2021-10-01. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT05323123?
The interventions under investigation include: PrEP Education (BEHAVIORAL), SPARK (BEHAVIORAL), HealthMpowerment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05323123?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.